| Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects (NCT00839683) | AstraZeneca | 2009-02-01 |
| Study of FibroGen (FG)-3019 in Subjects With Type 2 Diabetes Mellitus and Kidney Disease on ACEi and/or ARB Therapy (NCT00913393) | Kyntra Bio | 2009-02-01 |
| Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes (NCT00855166) | AstraZeneca | 2009-02-01 |
| Nutritional Prevention of Diabetes Mellitus Type 2 (NCT03231839) | University Hospital Tuebingen | 2009-02-01 |
| Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction> (NCT02181842) | Takeda | 2009-01-26 |
| Postprandial Dysmetabolism (NCT00813215) | Aarhus University Hospital | 2009-01-01 |
| Effect of Conjugated Linoleic Acid Alone and in Conjunction With Vitamin E in Patients With Type 2 Diabetes Mellitus (NCT01099163) | Shahid Beheshti University of Medical Sciences | 2009-01-01 |
| Welchol as Monotherapy for Type 2 Diabetes Mellitus (NCT00789737) | Daiichi Sankyo | 2009-01-01 |
| Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers (NCT00836225) | Ionis Pharmaceuticals, Inc. | 2009-01-01 |
| A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017) (NCT00792935) | Merck Sharp & Dohme LLC | 2009-01-01 |
| Protein Profile of Immunoregulatory Factors in Diabetic Cataract (NCT01832311) | University of Zagreb | 2009-01-01 |
| Aspirin Dosing in Diabetic Patients (NCT01201785) | University of Florida | 2009-01-01 |
| A Study to Test MK-0941 in Adults With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Insulin (MK-0941-018) (NCT00824616) | Merck Sharp & Dohme LLC | 2009-01-01 |
| Integrating Depression Services Into DM Management (NCT01098253) | University of Pennsylvania | 2009-01-01 |
| Sitagliptin Cardiovascular Outcomes Study (MK-0431-082) (NCT00790205) | Merck Sharp & Dohme LLC | 2008-12-10 |
| A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074) (NCT00813995) | Merck Sharp & Dohme LLC | 2008-12-09 |
| A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110) (NCT00830076) | Merck Sharp & Dohme LLC | 2008-12-02 |
| Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin (NCT00814372) | Gilead Sciences | 2008-12-01 |
| Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (NCT00822211) | Novartis | 2008-12-01 |
| Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty (NCT01150617) | IRCCS San Raffaele | 2008-12-01 |
| Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007) (NCT00806585) | Merck Sharp & Dohme LLC | 2008-12-01 |
| A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2) (NCT00846391) | Merck Sharp & Dohme LLC | 2008-12-01 |
| Determinants of Insulin-induced Weight Gain in Type 2 Diabetes Mellitus (NCT00781495) | Radboud University Medical Center | 2008-12-01 |
| Growth Hormone Feedback to Insulin-like Growth Factor-I (IGF-1) and Oral Glucose Tolerance Test (OGTT) (NCT00915954) | Cedars-Sinai Medical Center | 2008-12-01 |
| University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) (NCT00994682) | University of Florida | 2008-12-01 |
| Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II (NCT00799643) | Joslin Diabetes Center | 2008-11-01 |
| Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4) (NCT00676338) | AstraZeneca | 2008-11-01 |
| Impact of GBS on CVD in Type 2 Diabetes Mellitus (NCT00787670) | Duke University | 2008-11-01 |
| Januvia Re-examination Study (MK-0431-181) (NCT01062048) | Merck Sharp & Dohme LLC | 2008-10-01 |
| Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients (NCT01588743) | Li Guangwei | 2008-10-01 |
| Green Tea, High in Epigallocatechin Gallate (EGCG) and Postprandial Fat Oxidation (NCT00867555) | Maastricht University Medical Center | 2008-10-01 |
| Type 2 Diabetes Mellitus: New Approaches to Optimize Medical Care in General Practice (NCT00742547) | German Cancer Research Center | 2008-10-01 |
| Assessment of Thrombogenicity in Acute Coronary Syndrome (NCT00728286) | Newcastle-upon-Tyne Hospitals NHS Trust | 2008-10-01 |
| Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes (NCT00736879) | AstraZeneca | 2008-09-22 |
| MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2) (NCT00722371) | Merck Sharp & Dohme LLC | 2008-09-05 |
| Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms (NCT01844050) | Shanghai University of Traditional Chinese Medicine | 2008-09-01 |
| Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease (NCT00865124) | Brigham and Women's Hospital | 2008-09-01 |
| How Improvement in Control of Diabetes Influences the Production of a Hormone Produced in the Gut Which Improves the Release and Action of Insulin. (NCT00747383) | The Royal Bournemouth Hospital | 2008-09-01 |
| A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator (NCT00760578) | Metabolic Solutions Development Company | 2008-09-01 |
| An Investigation Into Bone Micro-architecture in Women With Type 2 Diabetes (NCT00982371) | Hamilton Health Sciences Corporation | 2008-09-01 |
| Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial (NCT00700856) | Italian Society of Diabetology | 2008-09-01 |
| Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione (NCT00729326) | AstraZeneca | 2008-08-01 |
| Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in Japan (NCT01318083) | Takeda | 2008-08-01 |
| Effect of Diabetes Mellitus on Cholesterol Metabolism (NCT00879710) | Medical College of Wisconsin | 2008-08-01 |
| Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients (NCT00744237) | Forest Laboratories | 2008-08-01 |
| Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) (NCT00707590) | Bristol-Myers Squibb | 2008-08-01 |
| Incretin Physiology Associated With Steroid Hormone Treatment (NCT00713440) | Glostrup University Hospital, Copenhagen | 2008-07-01 |
| Telephone Intervention in Patients With Acute Coronary Syndrome (ACS) and Diabetes (NCT00816010) | Chinese University of Hong Kong | 2008-07-01 |
| Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes (NCT00948168) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2008-07-01 |
| Safety and Efficacy Study of Dutogliptin/PHX1149T to Treat Type 2 Diabetes Mellitus (NCT00690638) | Phenomix | 2008-07-01 |
| GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia (NCT00716170) | Herlev Hospital | 2008-07-01 |
| Diabetes Prevention and Control in the Workplace: A Pilot Study (NCT00739336) | State University of New York - Upstate Medical University | 2008-07-01 |
| Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes (NCT00948324) | Sun Yat-sen University | 2008-06-01 |
| A Clinical Study of GRC 8200 in Type 2 Diabetes Mellitus (NCT00836940) | Glenmark Pharmaceuticals Europe Ltd. (R&D) | 2008-06-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients (NCT00707954) | Tanabe Pharma Corporation | 2008-06-01 |
| Influence of Diabetes on Tramadol Pharmacokinetics (NCT02246712) | Universidade Estadual Paulista Júlio de Mesquita Filho | 2008-06-01 |
| Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus (NCT00694057) | Harbor Therapeutics | 2008-06-01 |
| Evaluation of Exenatide in Patients With Diabetic Neuropathy (NCT00855439) | University of Michigan | 2008-06-01 |
| Genetic Variants and Phenotypic Characteristics of Patients With T2DM (NCT00760292) | Odense University Hospital | 2008-05-01 |
| Journey for Control of Diabetes Study (0431-111) (NCT00652509) | Merck Sharp & Dohme LLC | 2008-05-01 |
| Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy (NCT00655330) | Guangdong Provincial People's Hospital | 2008-05-01 |
| Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) (NCT00708578) | Sanofi | 2008-05-01 |
| The Effect of a Traditional Dietary Intervention on Diabetes Mellitus and Cardiovascular Disease Risk Factors in a First Nation Community: A Pilot Study (NCT00707460) | University of Toronto | 2008-05-01 |
| Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol. (NCT00591227) | Rush University Medical Center | 2008-05-01 |
| Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in Japan (NCT01318122) | Takeda | 2008-05-01 |
| Effect of SCH 497079 on Metabolic Parameters and Influence of Race/Ethnic Origin on Therapeutic Response (Study P05338)(COMPLETED) (NCT00673465) | Merck Sharp & Dohme LLC | 2008-04-17 |
| Diabetes Treatment With Glucobay in Combination With Sulfonylurea (NCT01613105) | Bayer | 2008-04-01 |
| Diabetes Treatment With Glucobay in Combination With Metformin (NCT01612741) | Bayer | 2008-04-01 |
| A Study of the Effects of Exercise Intensity on Insulin Sensitivity in Overweight Youth (NCT00755547) | University of Manitoba | 2008-04-01 |
| A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus (NCT00660309) | Novartis | 2008-04-01 |
| Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) (NCT00641056) | AstraZeneca | 2008-04-01 |
| A Study to Test the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK1006 (MK-1006-002)(COMPLETED) (NCT00757601) | Merck Sharp & Dohme LLC | 2008-04-01 |
| Antioxidant Effects of Pomegranate Juice Versus Placebo in Adults With Type 2 Diabetes Mellitus (NCT00668954) | University of Colorado, Denver | 2008-04-01 |
| Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes (NCT01156597) | University of Miami | 2008-04-01 |
| A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide (NCT00671424) | GlaxoSmithKline | 2008-03-01 |
| A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM (NCT00980187) | LaborMed Pharma S.A. | 2008-03-01 |
| The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes (NCT00653510) | University of Aarhus | 2008-03-01 |
| Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus (NCT00655603) | University Hospital, Gentofte, Copenhagen | 2008-03-01 |
| Shiga Progression of Diabetes, Nephropathy and Retinopathy (NCT00846716) | Shiga University | 2008-03-01 |
| Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans (NCT01354977) | Albert Einstein College of Medicine | 2008-03-01 |
| A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Who Are Currently on Metformin Monotherapy (NCT00674466) | ConjuChem | 2008-03-01 |
| Severe Insulin Resistance in Patients With Type 2 Diabetes (NCT00654056) | University of Aarhus | 2008-03-01 |
| Is There a Metabolic Effect of Cinnamon on HbA1c, Blood Pressure and Serum Lipids in Type 2 Diabetes Mellitus? (NCT00846898) | Thames Valley University | 2008-03-01 |
| Bone Marrow Mononuclear Cell and Hyperbaric Oxygen Therapy in Diabetes Mellitus (NCT00767260) | Fuzhou General Hospital | 2008-03-01 |
| 1,5-AG as a Marker of Postprandial Hyperglycemia and Glucose Variability in Well-controlled Type 2 Diabetes Mellitus (NCT01161797) | Kyunghee University Medical Center | 2008-02-01 |
| A Study to Evaluate the Efficacy and Safety of CJC-1134-PC in Patients With Type 2 Diabetes Mellitus Who Are Currently on Metformin Monotherapy (NCT00638716) | ConjuChem | 2008-02-01 |
| A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator (NCT00631007) | InteKrin Therapeutics, Inc. | 2008-02-01 |
| Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients (NCT00622323) | AstraZeneca | 2008-02-01 |
| Community Health Worker Reduces Care Utilization (NCT00711152) | Chinese University of Hong Kong | 2008-02-01 |
| Effects of Low Versus High Carbohydrate Diet During Rehabilitation on Cardiovascular Function and Metabolism in Type 2 Diabetes (NCT01004757) | Munich Municipal Hospital | 2008-02-01 |
| MK0431A vs. Pioglitazone in Patients With Type 2 Diabetes Mellitus (0431A-066) (NCT00532935) | Merck Sharp & Dohme LLC | 2008-01-26 |
| A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED) (NCT00541450) | Merck Sharp & Dohme LLC | 2008-01-15 |
| Effectiveness of Nursing Care Plans Based in Nursing Diagnoses in Metabolic Control of Type 2 Diabetes Mellitus (NCT01482481) | Hospital Carlos III, Madrid | 2008-01-01 |
| Exploration of the Lipid Metabolism During the Diabetic Pregnancies (NCT00639964) | University Hospital, Lille | 2008-01-01 |
| CHOICE: CHanges to Treatment and Outcomes in Patients With Type 2 Diabetes Initiating InjeCtablE Therapy (NCT00635492) | AstraZeneca | 2008-01-01 |
| Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus (NCT00607945) | Ohio State University | 2008-01-01 |
| Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease (NCT01006889) | University of Florida | 2008-01-01 |
| A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2) (NCT00637273) | AstraZeneca | 2008-01-01 |
| The Effect Of Glycemic Control On Malondialdehyde, Glutathione Peroxidase, Glutathione And Paraoxonase (NCT01467674) | Suleyman Demirel University | 2008-01-01 |
| Sitagliptin in Combination With Metformin and Sulfonylurea (NCT00686634) | Charles Drew University of Medicine and Science | 2008-01-01 |